One of the many hats I wear is that of an angel investor, a role that offers a front-row seat to the theater of dreams that is the startup world. My clinic is a place of sterile precision and predictable outcomes, but the startup pitches I hear are a different beast entirely. They’re vibrant, full of hope, and sometimes a bit too optimistic for their own good. It’s not that I’m jaded; I’ve just become adept at identifying when a pitch has a solid foundation and when it’s built on the quicksand of unrealistic ambitions.
I often find myself passing on most pitches within the first five minutes. It’s not that I don’t appreciate the hard work and passion that goes into them, but I’ve learned to recognize certain red flags that signal a potentially poor investment. Let me share why my decision is often so swift.
A few weeks ago, a young founder approached me with a pitch for a revolutionary app aimed at the education sector. At first glance, the idea was intriguing. But as he spoke, it became clear that his enthusiasm far outstripped his understanding of the complexities involved in educational reform. He had no clear plan for navigating the existing infrastructure or regulations — a classic case of underestimating the depth of the waters he was diving into. In those moments, I was reminded of what medicine has taught me about risk: you can’t treat a patient effectively if you ignore their medical history, just as you can’t disrupt an industry without understanding its intricacies.
In my experience, the best pitches come from founders who know their limitations. They’re like patients who come into my clinic, not just with an understanding of their symptoms but with a curiosity about the treatment process. They ask questions, they listen, and most importantly, they’re willing to learn. This is why I value emotional intelligence over business plans — it’s a trait that often predicts a founder’s ability to adapt and persevere. If you’re interested, I’ve elaborated on this in a piece titled “Why I Value Emotional Intelligence Over Business Plans in Startup Pitches”.
Another reason I might quickly pass on a pitch is the lack of transparency. Just as in IVF, where patients deserve to know the realistic chances of success, I expect founders to be forthright about challenges and risks. I’ve encountered too many pitches where the numbers seem too good to be true or the potential market is exaggerated to the point of absurdity. This isn’t just a red flag; it’s a deal-breaker. Transparency builds trust, and without it, no amount of innovation can save a pitch. For those interested, I’ve discussed this in detail in my blog post “Why I Insist on Transparency—In Both IVF and Startup Pitches”.
Then there’s the matter of focus. I’ve seen pitches that try to be everything to everyone. It reminds me of a patient who once came to me insisting on a treatment plan that covered every possibility without focusing on their primary issue. In startups, as in medicine, spreading yourself too thin is a recipe for failure. A successful pitch usually has a laser focus on solving a specific problem for a specific group of people. The best founders are those who understand their niche and are committed to serving it well before expanding their horizons.
Finally, there’s the matter of resilience. The startup journey isn’t a sprint; it’s a marathon fraught with setbacks and challenges. I’ve seen founders crumble at the first sign of trouble, much like patients who lose hope at the first sign of a failed treatment cycle. I’m more inclined to back a founder who has weathered a few storms and emerged stronger. These are the individuals who have learned from their mistakes, much like I have from my own missteps in both medicine and investing. For more on this, you might find my thoughts in “The Unexpected Lessons from a Startup’s First Misstep” enlightening.
In conclusion, my swift decision-making isn’t about dismissing dreams but about recognizing those that are grounded in reality. The most successful founders, much like the most successful patients, are those who come prepared, who are honest about their challenges, and who have the resilience to push through the inevitable tough times. Investing, like medicine, is about placing bets on the right people — those who have the courage to face the truth and the intelligence to act on it.
When I pass on a pitch, it’s often because I see the gap between vision and reality being too wide to bridge. In those moments, I’m not just an investor; I’m a mentor who hopes that the rejection will be a catalyst for growth and reflection. After all, the best lessons often come from the pitches we pass on, not the ones we accept.